In PD mouse models, oral administration of 0.1% glucoraphanin and repeated intrathecal injection of C/EBPβ‐HDO successfully prevented glial activation and reduced degeneration of TH neurons in the SNc. The gene discussed is CEBPB; the disease is Parkinson disease.